FDA Inspection 1251572 — Julitta Bradley, MD
The FDA completed an inspection of Julitta Bradley, MD on Sep 18, 2024 in Belize City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Belize City (Belize)
Additional Details
Clinical BA/BE